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Abstract: The limited penetration depth of visible light in biological tissues has encouraged re-
searchers to develop novel implantable light-guiding devices. Optical fibers and waveguides that
are made from biocompatible and biodegradable materials offer a straightforward but effective
approach to overcome this issue. In the last decade, various optically transparent biomaterials, as
well as different fabrication techniques, have been investigated for this purpose, and in view of
obtaining fully fledged optical fibers. This article reviews the state-of-the-art in the development of
biocompatible and biodegradable optical fibers. Whilst several reviews that focus on the chemical
properties of the biomaterials from which these optical waveguides can be made have been pub-
lished, a systematic review about the actual optical fibers made from these materials and the different
fabrication processes is not available yet. This prompted us to investigate the essential properties
of these biomaterials, in view of fabricating optical fibers, and in particular to look into the issues
related to fabrication techniques, and also to discuss the challenges in the use and operation of these
optical fibers. We close our review with a summary and an outline of the applications that may
benefit from these novel optical waveguides.
Keywords: biomedical materials; optical polymers; polymer optical fibers; fiber fabrication
1. Introduction
The last decade has witnessed an increasing interest in the development of optical
waveguides and fibers made from materials that are biodegradable and biocompatible,
in view of serving various medical applications. They can, for example, be implanted
during surgery and left inside the human body for the period required to monitor a specific
healing process. Once implanted, and after having fulfilled their mission, the bioresorbable
waveguides can be left to degrade and be eliminated via natural pathways. Implantable
optical waveguides can, not only be implemented to assist the straightforward delivery of
light inside the human body, but also to support more advanced tasks, including optoge-
netic stimulation [1], photodynamic therapy [2], cell imaging [3], and biological sensing [4].
The open literature already reports on the development of biodegradable optical fibers
made from a plethora of different materials for potential biomedical applications [5–9].
In this review article, we focus on two main challenges involved when developing such
waveguides: the fabrication process, and their eventual performance seen from an optical
standpoint. The first challenge relates to the material from which the waveguides are made
and how the waveguides are manufactured. The second relates to the duration over which
these waveguides can operate, considering their limited lifetime, which is governed by
their degradation rate.
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Figure 1 summarizes upfront how the four major aspects of the development of
biocompatible and biodegradable optical fibers are interrelated. The selection of the right
biomaterial, the actual fiber fabrication technique employed, and the design of the fiber
greatly impact the application potential. In this review, we intend to look into these
challenges, with a particular emphasis on fabrication approaches, and we will come back
to Figure 1 at the end of this manuscript. More specifically, we review different fabrication
strategies, as well as the common characteristics of the most employed biomaterials that
impact the waveguide fabrication and final performance. We pay particular attention to the
methods that allow mass manufacturing of biocompatible optical fibers, in view of ensuring
optimized production processes that can deliver products meeting the highest standards
in a repeatable manner. We also aim to provide a clear overview of the development of
biomaterial-based optical fibers, with an emphasis on their practicality. Finally, we discuss
future directions for developing biodegradable and biocompatible optical fibers and hint
at potential applications.
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Figure 1. Schematic representation of the four major challenges involved when developing biodegrad-
able and biocompatible optical fibers.
The remainder of our paper is structured as follows. In Section 2, we examine the
most important materials used for developing implantable optical fibers and focus on a
representative group of biomaterials. We highlight their advantages and disadvantages,
to provide a clear understanding of the influence of the material on the eventual device
performance. In Section 3, we report on the various techniques used for manufacturing
biocompatible and biodegradable optical fibers, and by doing so, we summarize the current
state-of-the-art in this field. Section 4 provides an overview of the remaining issues and
discusses the demands of high quality optical fiber performance upon implantation. We
close our manuscript with Section 5, including a summary supplemented with perspectives
for future research.
2. Material Properties Relevant for Implantable Optical Fibers
From an optical standpoint, the most important features of a material used to fabricate
optical waveguides are the optical transmittance and the refractive ind x. The refractive
ind x of an optical waveguid material must exceed tha of the surrounding medium,
to support total in ernal reflection and hence propagation of optical power within the
waveguide. The material should also feature both considerably low abso bance and
low scattering, as this is crucial to achieve low attenuation of the optical power as it
propagates down the w veguide. The biomaterials used for the fabrication of optical
fibers should also feature adequate mechanical properties. Sufficient elasticity and tensile
strength (i.e., 70 MPa for poly(methyl methacrylate) (PMMA) [10]) are important; the
material should endure fabrication processes such as fiber drawing. To ease processability
and to obtain satisfactory fiber properties, polymer materials should exhibit sufficiently
high molar mass (preferable in the range of 104–105 g/mol) to prevent filament breakage
under draw-down strain, and preferably be amorphous to enhance the mobility of the
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molecular chains to disentangle and orient in the fiber direction under strain. Additionally,
optical fibers should be sufficiently rigid to allow for implantation, but not too stiff or
brittle to avoid damaging the surrounding tissue. The thermal properties of the material
(e.g., the glass transition temperature, Tg, or the melting temperature, Tm) are therefore
crucial in view of the waveguide manufacturing process and their actual use and lifetime.
The biomaterials should exhibit a Tg above the physiological temperature of 37 ◦C, and
preferably even higher (e.g., above 50 ◦C). Furthermore, implanted fibers need to be
compatible with biological tissues and feature a low cytotoxicity. In other words, the
fiber must be capable of long-term contact (from several days to months) with living
tissues without causing an unacceptable degree of harm to the surrounding tissue and
the organism [11]. Additionally, the fiber should preferably be made from materials that
can degrade into products that can be excreted by the human body, and hence disappear
after use at a rate that is commensurate with the intended application, to prevent any risks
associated with surgical retraction.
Standard fused silica glass features excellently low attenuation and chemical inertness.
Whilst it is the most popular material for fabricating optical fibers, such glass fibers are
not adequate for implantation and long-term in vivo applications due to their mechanical
stiffness, fragility, and brittleness, and due to their lack of in vivo resorbability. Indeed,
glass shatters when it breaks, and sharp edges and debris could injure surrounding tissue.
The remaining debris would not disappear and would require surgical removal. Standard
silica-based optical fibers also feature inferior biocompatibility, which is another significant
hindrance for many biomedical applications. In this respect, natural and synthetic polymer-
based optical materials offer an interesting alternative, as these can be tailored to provide
appropriate physical, chemical, and biological properties and functionalities. Polymers can
be more readily functionalized with different surface chemistry techniques, for example
to provide sensitivity to specific chemical or biological agents. Polymer fibers do not
shatter when they break and some of them degrade following hydrolysis that is catalyzed
by enzymes.
The technology of polymer optical fibers (or plastic optical fibers), typically abbrevi-
ated as POFs, has greatly evolved in the last decades. The most common base material for
POFs is poly(methyl methacrylate), or PMMA. The typical operational spectral window for
a PMMA POF is around 650 nm, where the optical loss is of the order of 0.15 dB/m [12].
Whilst this is three orders of magnitude higher than the attenuation coefficient of 0.2 dB/km
at 1550 nm featured by standard telecommunication grade silica optical fiber, POFs of-
fer other advantages over silica fibers, such as higher fracture toughness, lower Young’s
modulus (around 3.2 GPa for PMMA [13]), and higher failure strain. PMMA POFs are
typically employed for short-distance optical communication applications or in healthcare
systems [14,15]. Besides plain PMMA, other polymers are also frequently used for the fab-
rication of POFs, such as its deuterated or fluorinated analogs [16]. Other examples include
polystyrene (PS), polycarbonate (PC) [17], amorphous fluorinated polymer CYTOP [18],
and cyclic olefins such as ZEONEX [19] or TOPAS [20,21]. Extended reviews about POFs,
the materials involved in their fabrication, and their applications can be found in [22–25].
Although the polymer materials mentioned above feature very interesting optical and
mechanical properties, none of them combine biocompatibility with biodegradability. In
this respect, biodegradable (both synthetic and natural) polymers (derived from renewable
resources) have gained increasing attention, not only due to their application possibilities,
but also owing to their relatively straightforward processability. Such biodegradable mate-
rials have been widely employed, mainly in packaging, agriculture, and medicine [26]. In
the medical field, more specifically, biodegradable polymers are used as sutures, implants,
scaffolds for tissue engineering, or as controlled drug delivery systems [26,27], and only
recently they have been investigated in the form of optical waveguides and fibers.
Some natural proteins (i.e., silk, collagen, fibrin) and polysaccharides (i.e., cellulose
agarose, chitosan) are natural biomaterials that demonstrate excellent biocompatibility
and biodegradability, and hence they have already been researched for various medical
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applications, including drug delivery [28] and tissue engineering [29–31]. They may
provide benefits over synthetic materials since they can more closely match the biophysical
properties of tissues within the human body. However, biologically derived materials are
generated by nature without strict control over the processes involved, and are limited
in terms of the availability of, or access to, the animal or vegetable resources, and hence
they may suffer batch-to-batch variation due to the natural variability in macromolecular
structures and their molar mass [32]. Natural polymers, especially the protein-based
varieties can be immunogenic [33], i.e., they may trigger an unwanted immune response.
In addition, natural biopolymers may carry a risk of transmitting infectious diseases when
improperly collected, stored, or manufactured [34]. Another significant problem is their
decomposition or pyrolytic modification at temperatures below their melting point, which
prevents the thermoforming of these materials according to predefined designs at higher
temperatures, for example with melt extrusion [35]. Finally, naturally derived materials are
typically characterized by poor optical transmittance.
Synthetic biomaterials are often produced from renewable resources and offer much
better material designability, as they are man-made products with adjustable physical, me-
chanical, and chemical properties. They can be created as degradable materials, meaning
that they can be resorbed by the human body, and their degradation profile and optical
properties can be tuned and optimized to meet the requirements of various optical de-
vices. When one synthetic biomaterial does not satisfy all the necessities, a combination
of various types, by means of blending or copolymerization, may allow meeting all the
requirements of the intended application. However, synthetic biomaterials also feature
disadvantages, because their structure and composition are not the same as those of native
tissues, hence their biocompatibility should always be evaluated. The biocompatibility
and flexibility of a biomedical device can be realized, for example, using hydrogels as
building materials, which are three-dimensional polymer networks that can occur either as
synthetic or natural polymers. Natural hydrogels feature excellent biocompatibility and
biodegradability. Due to their high water content, hydrogels resemble natural soft tissue
more than any other type of polymeric biomaterials and possess biologically recognizable
moieties that support cellular activities [36]. Their major limitations relate to an unsat-
isfactory mechanical strength [37], difficulties in obtaining a repeatable and controllable
product from natural resources due to their batch-to-batch variation [38], and the potential
to evoke inflammatory responses [36]. For these reasons, natural hydrogels are often
combined with synthetic counterparts. Synthetic hydrogels can be engineered to exhibit
more reproducible physical and chemical properties, as they can be molecularly tailored
with block structures, molecular weights, mechanical strength, and biodegradability [36].
Their material properties are adjustable, they can incorporate chemical functional groups,
and they are able to encapsulate drugs or cells [39]. Additionally, bioactive molecules
(i.e., RGD peptides or growth factors proteins, GFs) can be incorporated into the synthetic
hydrogel network during or after hydrogel formation for fabricating bioactive hydrogels
in order to mediate specific cell functions [36]. A key advantage, in terms of processing,
is that they are injectable or can be cast, since they are formed from liquid or soluble
precursors and can be crosslinked in situ by thermal- or photo-polymerization [40]. On
the other hand, their mechanical properties are often inadequate, as they typically have
low tensile strength, resulting in brittleness, which may render them unsuitable for some
in vivo applications [35,37].
At the other end of the material spectrum, more specifically that of inorganic materials,
degradable calcium-phosphate glasses (PGs) [41] have also been considered for fabricating
implantable optical fibers. PGs can be tailored by various fractions of calcium oxide (CaO)
and magnesium oxide (MgO), in order to adapt their refractive index and degradation rate.
The biggest advantage of PGs is their excellent optical transmission in the visible (VIS)
and near-infrared (NIR) range of the electromagnetic spectrum. On the other hand, the
rigidness and fragility of phosphate glass may provoke an undesirable immune reaction,
which limits their biocompatibility.
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The families of biomaterials discussed above, and examples thereof, are summarized
in Table 1, together with their main advantages and disadvantages.
Table 1. Summary of biomaterials used for optical fibers.
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3. Optical Fiber Fabrication Techniques
Typical polymer optical fiber production techniques applied in industry use either a
continuous or a discontinuous process flow. In the first type, all process steps run simultane-
ously, which ensures a high efficiency and production capacity. Continuous manufacturing
techniques include continuous extrusion, melt spinning, and photochemical polymeriza-
tion [42]. Typical discontinuous techniques involve heat-drawing or batch extrusion. These
processes consist of at least two steps that should run separately. Therefore, discontinu-
ous techniques typically deliver shorter fiber lengths than those obtained via continuous
processes. An important advantage, however, is that these fabrication techniques are not
restricted to a specific polymer type, since no in situ polymerization is needed. All the
optical fiber manufacturing technologies mentioned above can provide large amounts of
optical fibers (tens or hundreds of meters).
Besides the widespread manufacturing strategies including extrusion, co-extrusion,
and thermal drawing of optical fibers from preforms, other processing methods have also
been tested, such as direct fiber drawing from the melt and fiber casting in a mold following
thermal polymerization or photo-polymerization. These fabrication techniques generate
only short lengths of fiber (typically a few centimeters) and are chosen due to difficulties in
material processing caused by chemical or mechanical properties or limited amounts of
available biomaterial.
3.1. Thermal Drawing from Preforms
One of the most widespread fiber manufacturing techniques is the heat-drawing
process, which is well known from conventional silica glass fiber manufacturing. It allows
delivering kilometers-long optical fibers. Heat-drawing requires two fabrication stages. It
starts with a fabrication of a preform from pre-selected materials, which is essentially a
scaled-up version of the eventual fiber. A preform already contains a core and cladding
structure or an air-hole pattern in a solid rod, to result in, so-called, microstructured or struc-
tured optical fibers. The diameter is of the order of centimeters, which is much larger than
that of the optical fiber (typically tenths of a millimeter), whilst its length is much shorter.
The design of the cross-section of the preform should respect the geometric ratio of the
eventual fiber dimensions. The preform can be prepared via several techniques, including:
injection molding of molten polymers [43], extrusion [44], casting [45], thin-film rolling [46],
stack-and-draw technique [47], 3D printing [48,49], and assembling components via a
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rod-in-tube technique [50]. The second step of the heat-drawing process involves drawing
down this preform into an optical fiber using a heat-draw tower [42]. Illustrations of a
preform and a heat-draw process are shown in Figure 2.
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Thermal drawing, which is a standardized technique for silica glass fabrication, can
also be used for biodegradable and biocompatible fibers. A first, yet peculiar, structure of
biodegradable fiber was reported in 2007 [51]. . upuis et l. described a ble-core
porous fiber structure made from cel ulose butyrate (CB) tubes, with low r refract ve
index polydisperse hydroxypropyl cel ulose powder (HPC) suspended in air to obtain an
inner cladding. The core consisted of a ce lulose tube that could either be co lapsed to
support light delivery or remain open for potential drug delivery. The fiber was therma ly
drawn fro prefor s ade fr ercially ila le ll l se t r te t . he
preform was first preheated in the furnace of the drawing tower at a t mperature of
150 ◦C for one hour, and then the optical fiber was drawn at about 180 ◦C to a diameter of
around 450 µm. Despite the relatively high attenuation of around 1.1 dB/cm at 630 nm,
the fiber showed potential to detect changes in transmission when its pores were filled
with deionized water. This publication led to the proposal of a multifunctional fiber
that could possibly embody microfluidic functionalities and drug release. A. Dupuis
et al. also reported on biodegradable fibers created from biomaterials such as poly(L-
lactic acid), poly-ε-caprolactone (PCL), and cellulose derivatives [52]. Hollow core, step-
index (SI), and multilayer fibers were thermally drawn from preforms using standard
drawing towers. The preform fabrication process included various techniques, such as
co-rolling of plastic films to manufacture multilayered preforms consisting of several
materials: poly-ε-caprolactone (PCL) powder-filling with a higher refractive index into
lower refractive index cellulose butyrate (CB) tubes to form single core and multiple core
step-index structures; and solution-casting of hydroxypropyl cellulose inside the CB tubes,
which were subsequently solidified in a vacuum oven. All the manufactured fibers featured
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relatively high attenuation, significantly above 1 dB/cm at 633 nm [52,53]. The authors did
not discuss the actual degradation of their implantable optical fibers, nor did they report
an evaluation of their biocompatibility.
The use of commercial semi-crystalline polyesters, PLLA and PLGA, in the form of
fibers was first described by R. Fu et al. [54]. The authors studied in vivo deep-brain neural
activity by means of intracranial light delivery and detection based on fluorescence sensing
in living mice. Unclad poly(L-lactic acid) (PLLA) and poly(L-lactic-co-glycolic acid) PLGA
optical fibers were fabricated with a simplified thermal drawing process from molten
semi-crystalline polyester beads at 220 ◦C and using glass capillary tubes, resulting in short
fiber lengths of 5 cm and a diameter of about 220 µm. The propagation losses of these
fibers were also rather high, 1.64 dB/cm at 473 nm in air. The authors also reported the
evaluation of the biocompatibility and degradability of the implanted fibers in living mice
models. They demonstrated that PLLA-based optical fibers are great candidates for deep
tissue light delivery and detection.
In our own work, we have used an amorphous form of PLA, more precisely poly(D,L-
lactic acid) (PDLLA), to fabricate optical fibers [55]. PDLLA may be better suited for optical
fiber fabrication since, in contrast to PLLA, it is an amorphous material, which indicates
that a lower optical loss could be achieved. The manufacturing exploited a standard heat
drawing process from previously fabricated preforms in the shape of cylindrical rods,
which had been pre-manufactured by melting PDLLA granulates. The unclad PDLLA
fiber demonstrated an attenuation coefficient of 0.11 dB/cm at 772 nm, which is the lowest
loss reported so far for biodegradable optical polymer fiber. The degradation of the
unclad PDLLA fiber followed the trend of the bulk material degradation, which indicated
that fibers with the largest diameter of 600 µm degraded faster than those with smaller
diameters of 300 and 200 µm and featured more than 84% molar mass loss over a period of
3 months. We also evaluated the optical loss at 633 nm of these unclad PDLLA fibers during
immersion in physiological fluid, phosphate-buffered saline (PBS) at 37 ◦C and pH = 7.4,
confirming that PDLLA-based fibers can efficiently deliver light over a period of 30 min,
which is commensurate with that required for photodynamic therapy (PDT). In subsequent
work, we also reported on the fabrication of SI polyester-based fibers, in which the core
consisted of poly(D,L-lactic-co-glycolic acid) (PDLLA) and the cladding of poly(D,L-lactic
acid) (PDLLA) [56]. The preforms were prepared by means of a rod-in-tube technique
by melting granulates, and the core-cladding fibers were manufactured with a standard
heat drawing process. Cutback measurements returned a slightly higher attenuation
coefficient of 0.26 dB/cm at 950 nm for fibers with an outer diameter of 1000 ± 50 µm, a
core of 570 ± 30 µm, and a numerical aperture of 0.163. These SI PDLGA-PDLLA fibers
also demonstrated no additional optical loss caused by immersion in PBS during the first
30–40 min, which made them suitable candidates for PDT.
Very recently, S. Shadman et al. [57] developed specialty optical fibers consisting of
poly(D,L-lactic-co-glycolic acid) (PDLGA) combined with PMMA and poly-ε-caprolactone
(PCL). The biocompatible fibers were also fabricated by thermal drawing from preforms,
and the obtained fibers were available in various shapes, such as rectangular, cylindrical,
core-shell, and multi-material planar waveguides with channels placed on the sides of the
structure, to permit incorporation within biodegradable polymers. The authors reported
meters-long microstructured fibers that showed sufficient flexibility for knotting and
weaving. The authors emphasized the possibilities of complex release mechanism profiles
via morphological evolution of the degrading polymers in diffusion control delivery. The
optical characteristics of these microstructured fibers, however, were not reported.
S. Farajikhah et al. [58] demonstrated the fabrication of PCL based optical fiber with
tailored cross-sections, such as unclad solid-core filaments, hollow-core, and grooved
fibers, all thermally drawn from preforms. The PCL preforms were prepared by melting
PCL pellets at 80 ◦C for 17 h inside polypropylene and Teflon® molds of various shapes.
Subsequently, the PCL based fibers were drawn using a standard heat-draw tower at 85 ◦C.
The optical loss of a PCL hollow core fiber with a 200 µm internal diameter that was sealed
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prior to immersion in PBS was around 1.5 dB/cm at 635 nm at the beginning of the study
(day 0) and increased to around 2.5 dB/cm at 635 nm over 21 days of immersion, which
indicates the very stable optical working lifetime for these PCL based fibers. PCL fibers
with unclad solid cores, and those with various topographies treated with 0.1% (wt/vol)
gelatin, demonstrated good adhesion and proliferation of MCF-7 cells, which suggested
that these PCL fibers support cell attachment and growth. Moreover, cells were found
to attach to the PCL fibers to a lesser extent also without any prior gelatinization. PCL
fibers were demonstrated to be non-cytotoxic and hence suitable for biomedical application,
including tissue engineering.
As indicated earlier, resorbable phosphate glasses (PGs) have also been exploited to
produce optical fibers intended for use in the biomedical field [41,59]. By adapting the
ratios of calcium oxide (CaO) and magnesium oxide (MgO), the refractive index of the PGs
was tailored to form a core-cladding structure with a step-index profile. Thermally drawn
single-mode fibers had an outer diameter of 120 µm and a core diameter of 12 µm and fea-
tured an attenuation as low as 1.86 dB/m at 1300 nm and 4.67 dB/m at 633 nm, which is the
broadest wavelength range showing a relatively low propagation loss among all biodegrad-
able optical fibers. This resulted from the fact that glasses are typically highly transparent
and that glass fibers benefit from a well-developed manufacturing platform. However,
the preform processing of PGs is not standard for typical glass preforms and cannot yet
be realized by the conventional modified chemical vapor deposition (MCVD) [60] that is
typically employed with silica preforms. Instead, PGs processing allows for preform fabri-
cation by means of a rod-in-tube technique. D. Gallichi-Nottiani and D. Pugliese et al. [61]
recently demonstrated the fabrication of microstructured fiber preforms of bioresorbable
phosphate glass and subsequent fiber drawing. To form this complex preform, the authors
first obtained the outer tube by direct extrusion and subsequently they used a standard
stack-and-draw technique [47], for which the preform was prepared by stacking the ex-
truded capillaries within a tube. The authors demonstrated light guidance at 1300 nm, but
a full optical characterization was not reported.
Table 2 summarizes biodegradable optical fibers and waveguides fabricated by ther-
mal drawing of a preform as reviewed above.
Table 2. Summary of biodegradable and biocompatible optical fibers and waveguides manufactured by means of thermal
drawing from preforms.
Material Type Preform Fabrication Fiber Type Optical Loss Reference
CB, HPC CB commercial tubes filled withHPC powder
Double core porous,
diameter: 450 µm 1.1 dB/cm at 630 nm [51]
CA, PLLA Co-rolling CA commercial film withPLLA cast film
Core-cladding, SI
diameter: 860 µm 9.8 dB/cm at 633 nm [52]
CB CB commercial tubes Hollow corediameter: 393 µm 2.2 dB/cm at 633 nm [52]
CB, PCL CB commercial tubes filled with PCLpowder
Core-cladding, SI
diameter: 420 µm 6.7 dB/cm at 633 nm [52]
CB, PCL
Inserting small diameter CB tube
into a larger diameter CB tube and
filling the space between with PCL
powder
Multiple core, SI
diameter: 410 µm 8.3 dB/cm at 633 nm [52]
CB, HPC
Inserting small diameter CB tube
into a larger diameter CB tube and
filling the space between tubes with
HPC powder dissolved in water
Porous cladding, SI
diameter: 415 µm 3.1 dB/cm at 633 nm [52]
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Table 2. Cont.
Material Type Preform Fabrication Fiber Type Optical Loss Reference
PLLA
PLGA
No preform. Simplified thermal
drawing directly from molten




1.6 dB/cm at 473 nm [54]
PDLLA Melting the PDLLA granulates inform of a homogenous rod
Unclad PDLLA fibers
diameter: 600, 300, 200 µm
0.11 dB/cm at 772 nm
0.17 dB/cm at 636 nm [55]
PDLLA, PDLGA
Rod-in tube technique: melting the
PDLLA granulates in Teflon® molds
in the form of a tube and PDLGA
granulates in form of homogenous
Core-cladding, SI fibers,
diameter: 1000 ± 50 µm,
where core is 570 ± 30 µm
0.26 dB/cm at 950 nm






multimaterial preforms prepared by
hot-pressing a base polymer plate
(i.e., PMMA or PLGA) and milling







PLGA tube fabricated in a hollow
core mold in the oven. The mold
was taken out and the core was
filled with PCL powder, and heated
Core-cladding fibers —– [57]
PCL
PCL preforms prepared by melting
PCL pellets inside polypropylene
and Teflon molds of circular, three-
and four-leaf cross-sectional shapes
at 80 ◦C for 17 h
Unclad solid-core and
grooved fibers; diameter
around 700 µm, hollow
core with internal diameter
200 µm
1.5 dB/cm at 635 nm in
PBS and 2.5 dB/cm




Rod-in-tube technique: rod made
from a previously drawn thicker rod,






0.047 dB/cm at 633 nm
[41,59]
PGs
Direct extrusion of outer tube and
standard stack-and-draw technique
by assembling extruded capillaries
within the tube
Microstructured fibers —– [61]
3.2. Extrusion and Extrusion-Based 3D Printing
In an extrusion process, a molten material (typically a polymer or a soft glass) is forced
through a die with a dedicated pattern. In the case of continuous extrusion, a mixture
of monomers, initiators, and additives is extruded in a continuous fashion during which
the polymerization reaction occurs inside the reactor while the material is being extruded.
Batch extrusion is a discontinuous process and permits a direct polymer fiber fabrication
technique, which is applied in two steps. In the first step, monomer, initiator, and other
additives, such as dopants, are inserted using a vacuum pump into a reactor, in which
the polymerization takes place [42]. After full conversion of these starting materials, the
temperature of the reactor is raised to generate a polymer melt. In the second step of the
process, the polymer melt is pumped through a spinning nozzle to be extruded in the
form of filament or unclad fiber. The batch extrusion can also be carried out starting with
commercial polymer pellets or granulates [62]. Extrusion-based additive manufacturing
(AM), or so-called 3D printing systems, have already been widely used for fabricating
tissue engineering scaffolds [63,64]. The extrusion-based modules typically use high forces
and temperatures to dispense materials through a micro-nozzle. Typically, the type of
the extruded fiber or preform shape depends on the employed extrusion die. Hence, the
extrusion method also allows manufacturing air-holed structures in polymer materials if the
employed die has a holey pattern [65], which in its turn enables fabricating microstructured
or structured optical fibers. Step-index fiber can also be fabricated using this technique,
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as different refractive index materials can be co-extruded to obtain core and cladding
layers simultaneously [66]. Figure 3 illustrates optical fiber extrusion and extrusion-based
3D printing.







Figure 3. Illustrations of (a) optical fiber extrusion, (b) 3D extrusion-based printing. 
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the glass substrate. Their attenuation was around 0.25 dB/cm at 633 nm. Silk fibers were 
also obtained by direct reeling of fiber collected from the female spider’s major ampullate 
glands onto a spool under controlled conditions at a constant speed of 5 mm/second. 
These silk fibers also had a small diameter of approximately 5 μm, which complicates the 
coupling of light to the fiber. In addition, scattering and absorption of the silk material 
resulted in large propagation losses, of approximately 10 dB/cm at 630 nm [68]. 
Recently, PEG-based hydrogel precursors, specifically pre-polymers of poly(ethylene 
glycol) diacrylate (PEGDA) reacted with thiol groups of DTT (DL-dithiothreitol), have 
also been investigated for manufacturing optical waveguides [69]. Feng J. et al., worked 
with an extrusion-based printing technique following in situ photopolymerization using 
a 3D-bioscaffolder to fabricate hydrogel-based optical waveguides in the form of unclad 
PEGDA-DTT and step-index fibers, in which PEGDA-DTT formed the core and acrylated 
Pluronic F127-DA formed the cladding. The SI fibers were printed using a coaxial printing 
needle with varying core diameters, ranging from 340 to 640 µm and with a fixed outside 
diameter of 1.02 mm. The authors reported that continuous lengths of 50 cm could be 
achieved using this fabrication technique. These hydrogel-based fibers showed improved 
light guidance, featuring optical losses of 0.1 dB/cm at 520 nm, 0.4 dB/cm at 405 nm in air, 
and 0.25–0.7 dB/cm once inserted in tissue. Printed PEGDA-DTT waveguides demon-
strated the possibility of activating optogenetic switches in cells using light delivery, and 
to control cell adhesion and their migration in a photo-responsive 3D culture of a fibro-
blast spheroid within a polymeric matrix. 
An alternative extrusion method used to fabricate cellulose-based optical fibers in-
cluded a wet-jet spinning device equipped with a spinning nozzle. H. Orelma et al. [70] 
reported the fabrication of a core filament that was made from cellulose dissolved in 
Figure 3. Illustrations of (a) optical fiber extrusion, (b) 3D extrusion-base rinting.
Using this technique, naturally derived spider silk has been employed to form optical
waveguides. The extruded silk waveguides were generated through direct ink writing
from an aqueous silk fibroin solution by S. Pa ker t al. [67]. Silk waveguides were printed
on borosilicate glass slides in both straight and wavy configurations, with lengths of several
centimeters and a diameter of around 5 µm; but they were not handled away from the
glass substrate. Their attenuation was around 0.25 dB/cm at 633 nm. Silk fibers were
also obtained by direct reeling of fiber collected from the female spider’s major ampullate
glands onto a spool under controlled conditions at a constant speed of 5 mm/s. These silk
fibers also had a small diameter of approximately 5 µm, which complicates the coupling of
light to the fiber. In addition, scattering and absorption of the silk material resulted in large
propagation losses, of approximately 10 dB/cm at 630 nm [68].
Recently, PEG-based hydrogel precursors, specifically pre-polymers of poly(ethylene
glycol) diacrylate (PEGDA) reacted with thiol groups of DTT (DL-dithiothreitol), have
also been investigated for manu acturing optical waveguides [69]. Feng J. et al., worked
with an extrusion-based printing technique following in situ photopolymerization using
a 3D-bioscaffolder to fabricate hydrogel-based optical waveguides in the form of unclad
PEGDA-DTT and step-index fibers, in which PEGDA-DTT formed the core and acrylated
Pluronic F127-DA formed the cladding. The SI fibers were printed using a coaxial printing
needle with varying core diameters, ranging from 340 to 640 µm and with a fixed outside
diameter of 1.02 mm. The authors reported that continuous lengths of 50 cm could be
achieved using this fabrication technique. These hydrogel-based fibers showed improved
light guidance, featuring optical losses of 0.1 dB/cm at 520 nm, 0.4 dB/cm at 405 nm
in air, and 0.25–0.7 dB/cm once inserted in tissue. Printed PEGDA-DTT waveguides
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demonstrated the possibility of activating optogenetic switches in cells using light delivery,
and to control cell adhesion and their migration in a photo-responsive 3D culture of a
fibroblast spheroid within a polymeric matrix.
An alternative extrusion method used to fabricate cellulose-based optical fibers in-
cluded a wet-jet spinning device equipped with a spinning nozzle. H. Orelma et al. [70]
reported the fabrication of a core filament that was made from cellulose dissolved in
[EMIM] AcO, which was passed through a nozzle into a water coagulation bath that was
kept at a constant spinning rate of 0.5 mL/min. After spinning, the filaments were stored
in water for 2 h and subsequently dried under tension at room temperature and ambient
humidity. The cladding was applied by coating the core filament by the cladding layer
using a lab coater. The cladding consisted of cellulose acetate dissolved in acetone that was
produced by coating the prefabricated regenerated cellulose filament core with a cellulase
acetate. The acetone was subsequently evaporated from the coated filament at room atmo-
sphere overnight. The diameter of the cellulose-based fiber was approximately 210 µm, and
the cellulose acetate cladding thickness was 3.40 ± 0.20 µm. The longest fabricated fiber
was around 76 mm, and the minimum attenuation of 5.9 dB/cm was found at 1130 nm.
In the wavelength range of 750–1350 nm, the optical loss was below 10 dB/cm, which is
still considered relatively high for a step-index fiber. The authors indicated the sensing
potential of these hydrogel-based fibers by immersing them in water and measuring the
increase of the attenuation, which appeared to be a reversible process.
3.3. Casting in a Mold and Curing
Casting has been typically applied to produce both silica glass and polymer preforms,
which were consequently thermally drawn to optical fibers. For glass materials, casting
involves low temperature sol-gel technology, in which an intermediate preform is formed
by pouring the sol into a mold where it is turned into a gel by lowering its pH. At the
wet gel stage, the cast mandrel elements are removed, leaving air columns within the
gel body. The gel body is then treated to remove water, as well as organic and transition
metal contaminants. The dried porous gel body is subsequently sintered at around 1600 ◦C
into viscous glass and finally drawn into an optical fiber [71]. For polymer materials, the
polymer preform is typically formed by in situ chemical polymerization [72]. First, all
the necessary chemical precursors (i.e., monomer, initiator, and chain-transfer agent) are
inserted into a mold that mirrors the preform geometry. The polymerizing mixture requires
degassing to prevent the formation of bubbles, or the reaction should be initiated in vacuum
conditions. Another method involves the solution casting of the initial polymer in a suitable
solvent (e.g., chloroform), which is followed by drying at room temperature or in vacuum.
Alternatively, with degradable thermosets after solution casting, the pre-polymer is cured
as it undergoes cross-linking reactions to form three-dimensional networks. The cross-
linking reaction happens with the aid of cross-linking agents combined with exposure
to high temperature or UV radiation, depending on the material. Once the curing is
completed, the solid structure is released from the mold. Figure 4 illustrates a typical
casting process followed by curing. The main advantages of casting methods are simplicity,
low production cost, and the possibility of machining the mold to obtain preforms or short
fibers with arbitrary shapes.
As previously indicated, casting represents a very straightforward method for fab-
ricating short lengths of fibers directly in a mold. Besides this, casting has been used to
apply a cladding layer to a previously fabricated unclad optical fiber. This technique was
employed to fabricate step-index silk waveguides with a core made of high-index silk
fibroin and a hydrogel lower index cladding. The step-index silk fibers were prepared
in two steps. First, the silk solution was cast into a mold and after drying into films,
the silk films were surrounded by a hydrogel solution cast inside a Teflon® tube prior to
gelation. The attenuation coefficient of around 2 dB/cm at 540 nm was mainly caused by
the roughness of the silk film [73]. Qiao, X. et al. [74] reported the fabrication of implantable
spider silk-based optical waveguides, made both from recombinant spider silk protein and
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regenerative silkworm silk protein, which was cast into Teflon® tubes with inner diameters
of 800 µm. The regenerative silkworm silk featured a refractive index n = 1.52, whilst for
the recombinant spider silk this was n = 1.70 at 635 nm. This led to propagation losses of
approximately 0.8 dB/cm at 635 nm in air and 1.9 ± 0.3 dB/cm in vivo in mice [74].




Figure 4. Principle of optical fiber fabrication by casting: pouring pre-polymer solution into a 
mold followed by either UV curing or thermal curing. 
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of 800 µm. The regenerative silkworm silk featured a refractive index n = 1.52, whilst for 
the recombinant spider silk this was n = 1.70 at 635 nm. This led to propagation losses of 
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M. Choi et al. [75] manufactured a hydrogel-based step-index optical fiber with a 
two-step process that consisted of a poly(ethylene glycol) (PEG) core and an alginate clad-
ding. First, the core was formed inside a silicone mold in a tube shape. The precursor 
solution for the PEG hydrogel with a radical photo-initiator (2-Hydroxy-2-methylpropio-
phenone) was injected into this tube and subsequently photo-crosslinked by exposure to 
UV light. To retrieve the core from the mold, the mold was immersed in dichloromethane 
until the silicone mold became swollen and the PEG core could be extracted. Next, the 
core with a diameter of around 250–800 µm was dipped multiple times in a sodium algi-
nate (SA) solution and calcium chloride solution to obtain physical crosslinking between 
the carboxyl group (–COOH) of SA to the calcium ion (Ca2+) of the CaCl2, and by doing so 
to generate alginate cladding with a desired thickness (typically around 100−150 µm). The 
authors did not report the total length of the fabricated fibers using this technique, but 
showed a photograph of a 1 m-long fiber. The fibers demonstrated losses below 0.42 
dB/cm across the VIS range, and insertion into the intestine of living mice confirmed that 
light delivery through tissue was achieved, indicating the potential for deep tissue photo-
thermal or photodynamic therapy. The PEG based core allowed incorporating various 
functional materials, including organic dyes-(rhodamine 6G, as well as biotin-conjugated 
fluorophores) for the generation of fluorescence. PEG was also examined by S. Nizamoglu 
Figure 4. Principle of optical fiber fabrication by casting: pouring pre-polymer solution into a mold followed by either UV
curing or thermal curing.
M. Choi et al. [75] manufactured a hydrogel-based step-index optical fiber with a two-
step process that consisted of a poly(ethylene glycol) (PEG) core and an alginate cladding.
First, the core was formed inside a silicone mold in a tube shape. The precursor solution
for the PEG hydrogel with a radical photo-initiator (2-Hydroxy-2-methylpropiophenone)
was injected into this tube and subsequently photo-crosslinked by exposure to UV light.
To retrieve the core from the mold, the mold was immersed in dichloromethane until the
silicone mold became s ollen and the PEG core could be extracted. Next, the core with
a diameter of around 250–800 µm wa di ped mult ple t mes in a sodium alginate (SA)
solution and calcium chloride solution to obtain physical crosslinking between the carboxyl
group (–COOH) of SA to the calcium ion (Ca2+) of the CaCl2, and by doing so to generate
alginate cladding with a desired thickness (typically around 100–150 µm). The authors
did not report the total length of the fabricated fibers using this technique, but showed a
photograph f a 1 m-long fibe . The fibers d monstr ted losses below 0.42 dB/cm across
the VIS range, and insertion into the intestine of living mice confirmed that light delivery
through tissue was achieved, indicating the potential for deep tissue photothermal or
photodynamic therapy. The PEG based core allowed incorporating various functional ma-
terials, including organic dyes-(rhodamine 6G, as well as biotin-conjugated fluorophores)
for the generation of fluorescence. PEG was also examined by S. Nizamoglu et al. [76], who
reported on the manufacturing of planar waveguides from hydrogel for photochemical tis-
sue bonding (PTB) in porcine skin wounds. PEG hydrogel-based planar waveguides were
prepared by photopolymerization of a precursor solution containing 80 wt% polyethylene
glycol diacrylate, 15 wt% water, and 5 wt% 2-hydroxy-2-methylpropiophenone using a
UV lamp. The optical properties of these waveguides were not reported. A very similar
approach of solution casting of liquid alginate-polyacrylamide precursor hydr gels was
used by J. Guo et al. [77] to obtain hydrogel-based core-cladding optical fibers with an
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enhanced toughness and stretchability. This was done by means of a hybrid polymer
network that contained both ionic and covalent bonds included in hydrogels to upgrade
their robustness. The core was fabricated by injecting a solution containing Ca2+ alginate
polyacrylamide (PAAm) precursor solution into a silicone tube mold with a syringe and UV
curing. After polymerization, the core was extracted from the mold by swelling the tube
in dichloromethane. Subsequently, the cladding was added directly onto the core by dip-
coating and photopolymerized under UV light to form a step-index structure. To ensure
robust bonding between the core and cladding, alginate was chemically anchored using
EDC/NHS chemistry and additionally, ionic cross-linking of Ca2+ in alginate cladding
was applied. The fibers were developed for strain sensing and could be stretched repeti-
tively to an axial strain up to 730% without deformation. The authors claimed that these
hydrogel-based stretchable optical fibers are suitable candidates for optical strain sensors
in wearable devices.
A first step-index biodegradable optical fiber was produced from polyester-based
elastomers by D. Shan et al. [78]. In this fiber, the core was made of poly(octamethylene
maleate citrate) (POMC), while the cladding consisted of poly(octamethylene citrate)
(POC). The step-index optical fibers were manufactured by thermal crosslinking (at 70 ◦C
for 4 days) of a pre-polymer cladding material in the form of a tube surrounding a stainless-
steel wire with a diameter 500 µm. Next, to remove the POC cladding tube from the wire,
the polymer-coated wire was immersed in 30% ethanol solution overnight, and the POC
tube was retrieved from the metal wire after swelling in ethanol. In the third step, the
authors used air pressure infiltration of the liquid POMC into the pre-polymerized POC
tube, which was followed by thermal crosslinking of both combined parts for another
3 days at 80 ◦C. D. Shan et al. did not reveal the total fiber length, but they reported on
experiments with a longest tested fiber sample of 7 cm. The propagation loss of 0.4 dB/cm
at 633 nm allowed delivering enough light deep into tissue, which was tested by placing a
fiber under a slice of porcine tissue with a thickness of ~2 mm under bending angles of 0◦,
30◦, and 90◦. Additionally, the authors demonstrated fluorescence sensing in vivo using an
agar gel doped with Rhodamine B dye in the abdomen area of a rat. Two fibers with a length
of 7 cm were inserted into the animal, first for the dye-excitation at 532 nm, and the second
for the collection of the emitted red fluorescent light. D. Shan et al. also showed an early
proof-of-concept of image transmission through this citrate-based polymeric optical fiber.
They applied spatial patterns on a digital micromirror device projected onto the proximal
end of the fiber by a He-Ne laser through an imaging telescope unit. To monitor the pattern
projection, a pellicle beam splitter with a splitting ratio of 8:92 (reflection: transmission), in
conjunction with an imaging setup, was used. The corresponding output image pattern
at the distal end of the citrate-based fiber was registered with a charge-coupled device
(CCD) camera. Due to the multimodal light propagation in the fiber, the output projection
contained random speckle patterns and did not completely match the input pattern, hence
image reconstruction was applied.
Recently, E. Fujiwara et al. [79] reported on the manufacturing of structured agarose
optical fibers with a solid core surrounded by six air holes. The fiber was made by directly
pouring solubilized agarose into a glass mold (inner diameter = 3 mm) with six internal
rods (diameter = 0.5 mm). The agarose-based fiber demonstrated a loss of 3.23 dB/cm at
633 nm, with the prospect of application for in vivo biochemical sensing, as demonstrated
by measuring the output speckle intensity as an effect of different fluids inserted into the
air holes.
Table 3 summarizes the fabrication techniques for different optical fibers made from a
variety of biomaterials, together with their optical loss.
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Table 3. Summary of optical fibers and waveguides manufactured by means of extrusion, compression molding, and
solution casting followed by curing.
Material Type Fabrication Technique Fiber Type Optical Loss Reference
Silk fibroin direct ink extrusion applied under pressurefrom aqueous silk solution
unclad silk fibers on glass slides
diameter: 5 µm 0.25 dB/cm at 633 nm [67]





extrusion printing technique using a
commercial 3D-bioscaffolder, followed by
UV photopolymerization
unclad hydrogel-based fibers and
core-cladding hydrogel-based
fiber diameter:
core from 340 to 640 µm and total
diameter of 1.02 mm
0.1 dB/cm at 520 nm







the regenerated cellulose core was produced
from (EMI- M) OAc by using dry-jet wet
spinning in water bath as a coagulant. The
cladding was produced by coating the
cellulose core with cellulose acetate dissolved
in acetone.
core-cladding, SI diameter: core:
210 µm, cladding: 3.40 µm
6.3 dB/cm at 1300 nm,
~ 10 dB/cm in the
750–1350 nm
[70]
PLA and PLGA compression molding of polyester powdersand laser cut of polymer sheets planar waveguide 1.6 dB/cm at 635 nm [76]
Silk fibroin and
silk hydrogel 1
silk solution was cast into a mold as a core
and dip-coating of core in silk hydrogel
solution prior to gelation in a Teflon tube as
a cladding
core-cladding






genetically engineered spider silk protein
generated by means of biosynthesis.
Recombinant spider silk protein was
dissolved in hexafluoro-2-propanol at 37 ◦C
overnight, whilst regenerated silkworm silk
solution was directly cast into Teflon® tubes
with inner diameters of 800 µm. Protein
solutions in the molds were heated at 60 ◦C
for 7 days for complete solidification.
unclad fibers
diameter: 700 µm 0.8 dB/cm at 635 nm [74]
PEG as core and
alginate as cladding
precursor solution for PEG hydrogel was
injected into mold tube and
photo-crosslinked by UV. The PEG core was
dipped multiple times in a sodium alginate
and calcium chloride to form cladding
core-cladding, SI,
diameter: core: 250–800 µm,
cladding 100–150 µm
0.42 dB/cm at 492 nm [75]





precursor solution of acrylamide with Na
alginate was injected into a silicone tube
mold using a syringe and crosslinked at
50 ◦C under UV for 30 min.
unclad fibers,





precursor solution of acrylamide with Na
alginate was injected into a silicone tube
mold using a syringe and crosslinked at
50 ◦C under UV for 30 min. The unclad fiber
was dipped in an
Na-alginate-polyacrylamide precursor. The
clad-coated core fiber cured by UV
irradiation for 30 min. Fiber was immersed in
an aqueous solution of CaCl2 for ionic
cross-linking of alginate by Ca2+
for robustness
core-cladding, SI
diameter: 750 µm core and
1100 µm cladding
0.45 dB/cm at 532 nm [77]
POC pre-polymer,






and OD as core
thermal crosslinking of a pre-polymer
cladding material in the form of a tube
surrounding metal wire. Air pressure
infiltration of liquid POMC into the
pre-polymerized POC tube, which followed
the thermal crosslinking of both at 70 ◦C for
7 days.
core-cladding, SI,
diameter: 750 µm 0.4 dB/cm at 633 nm [78]
Agarose
boiled agar solution poured into the glass
mold tube with rods, cooled down and
released after solidification
structured fiber with 6 holes
diameters of core: 0.64 mm,
cladding: 2.5 mm, and air holes:
0.5 mm
3.23 dB/cm at 633 nm [79]
1 Hydrogel prepared by mixing silk fibroin solution, horseradish peroxidase (10 U/mL), and 10 µL/mL of 1% hydrogen peroxide.
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4. Challenges in Biocompatible and Biodegradable Optical Fiber Fabrication
and Operation
As already highlighted above, the fibers that are the subject of this review must
simultaneously meet optical (tailored refractive index, low optical loss), mechanical (ade-
quate mechanical flexibility for tissue compliance), and biological (biocompatibility and
adaptable biodegradability) requirements.
One of the most important parameters for an optical fiber is its optical transparency,
defined by the attenuation coefficient that reveals the optical loss following propagation
over a certain distance down the fiber. The fibers that we have reviewed so far display
attenuation coefficients between 10 dB/cm and 0.02 dB/cm, depending on the biomaterial
from which they are made, their structure, and the fabrication process, as well as on the
wavelength at which the optical loss measurement was conducted. Figure 5 shows the
attenuation coefficients for the various fibers as a function of wavelength.




boiled agar solution poured into the glass mold 
tube with rods, cooled down and released after 
solidification 
structured fiber with 6 holes 
diameters of core: 0.64 mm, clad-
ding: 2.5 mm, and air holes: 
0.5 mm 
3.23 dB/cm at 633 
nm 
[79] 
1 Hydrogel prepared by mixing silk fibroin solution, horseradish peroxidase (10 U/mL), and 10 μL/mL of 1% hydrogen peroxide. 
4. Challenges in Biocompatible and Biodegradable Optical Fiber Fabrication and Op-
eration 
As already highlighted above, the fibers that are the subject of this review must sim-
ultaneously meet optical (tailored refractive index, low optical loss), mechanical (adequate 
mechanical flexibility for tissue compliance), and biological (biocompatibility and adapt-
able biodegradability) requirements. 
One of the most important parameters for an optical fiber is its optical transparency, 
defined by the attenuation coefficient that reveals the optical loss following propagation 
over a certain distance down the fiber. The fibers that we have reviewed so far display 
attenuation coefficients between 10 dB/cm and 0.02 dB/cm, depending on the biomaterial 
from which they are made, their structure, and the fabrication process, as well as on the 
wavelength at which the optical loss measurement was conducted. Figure 5 shows the 
attenuation coefficients for the various fibers as a function of wavelength. 
 
Figure 5. Reported attenuation coefficient of optical fibers made from different biomaterials. The 
numbers between square brackets indicate the corresponding reference. 
Synthetic polymers (e.g., PLA, PDLLA, and PLGA) seem to provide fibers with su-
perior characteristics over natural polymers, since their properties, e.g., mechanical and 
physical properties or degradation rate, can be adapted to particular applications. These 
polymeric biomaterials are commercially available and feature sufficient mechanical 
strength in view of material processing, as well as maintaining stable working perfor-
mance. Furthermore, these biopolymers have been the subject of years of scientific re-
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the degradation and biocompatibility of PDLLA and PDLGA have already been reported 
with no clinical signs of foreign-body reactions to these materials [80]. Significant progress 




















































Figure 5. Reported attenuation coefficient of optical fibers made from different biomaterials. The
numbers between square brackets indicate the corresponding reference.
Synthetic polymers (e.g., PLA, PDLLA, and PLGA) seem to provide fibers with
superior characteristics over natural polymers, since their properties, e.g., mechanical
and physical properties or degradation rate, can be adapted to particular applications.
These polymeric biomaterials are commercially available and feature sufficient mechanical
strength in view of material processing, as well as maintaining stable working performance.
Furthermore, these biopolymers have been the subject of years of scientific research, result-
ing in several PLA and PLGA-based medical products that are approved and regulated
by the US Food and Drug Administration (FDA). In addition, clinical studies of the degra-
dation and biocompatibility of PDLLA and PDLGA have already been reported with no
clinical signs of foreign-body reactions to these materials [80]. Significant progress on
implantable fibers has also been made with phosphate glass. Such PG reveals excellent
transparency, featuring an attenuation coefficient that is one order of magnitude lower
than the attenuation of polymer optical fibers [41]. Phosphate based glass fibers proved
to be resorbable in vivo [81] and demonstrated good biocompatibility with tissues [81,82].
PG-based fibers demonstrated the potential to be fabricated with a small diameter, yielding
single mode guidance. They also allow for microstructuring [61] and for the inscription
of fiber Bragg gratings (FBG) [59], which are well-known fiber-based sensor elements
that allow projecting advanced biosensing applications. One still needs to account for
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the fragility of PG-based fibers. They are prone to crystallization, as their viscosities are
much lower than silicates [83], hence the fiber drawing might be troublesome and can
require rapid quenching or drawing of the fiber directly from a melt [84]. To avoid brit-
tleness, an additional coating could be applied to reinforce PG-based fibers using other
polymeric biomaterials.
The selection of the biomaterial primarily impacts the possible approaches for fiber
manufacturing. As discussed earlier, three main techniques have been employed for
fabricating biocompatible and biodegradable optical fibers, i.e., thermal drawing, extrusion-
based printing, and casting. Only the first two enable producing relatively larger fiber
lengths. One can therefore conjecture that those have the best potential to deliver a product
with a stable batch-to batch consistency, at a competitive cost. Although there is no demand
for implanting a fiber that is several meters long in a human body, it is important to deliver
excellent products characterized by a repeatable performance.
A third major influence on fiber performance stems from its structural design. Planar
optical waveguides with limited capacity to confine and guide or unclad optical fibers
are prone to large optical losses as soon as they are embedded into tissue. Step-index or
microstructured fibers are likely needed to ensure stable operation in vivo. In addition, the
degradation rate of the biomaterial-based fiber governs how long it takes for an implanted
fiber to be resorbed, and this largely depends on the biomaterial itself, as well as on the
fiber dimensions and on the implantation site. The required operational period of the fiber
can vary from minutes to hours, depending on the application scenario. In the case of
long-term health monitoring and drug delivery, this can even be days or weeks. So far, the
open literature offers very limited data regarding optical losses caused by implantation
in vivo or in a simulated biological environment.
At this stage we would like to go back to Figure 1, with which we started our paper,
and which attempts to illustrate the discussion above and highlight how the different
aspects dealt with so far are interrelated. The selection of a certain biomaterial not only
strongly impacts the possible manufacturing technology and the fiber design, but it also
affects the application potential. Consider for example a PDT scenario which exploits a
photosensitive cancer killing agent that is activated by a specific wavelength emitted by a
surgical laser that needs delivery through an implanted optical fiber. One must take into
account a biomaterial that shows low loss at that particular wavelength. Additionally, it
requires an optical source that provides for a broad and uniform illumination to obtain the
most effective and consistent PDT treatment [85], and therefore the fiber should possess a
large numerical aperture or its distal end may have to be terminated with a radial diffuser,
which could be in the form of cylindrical elongated sections that scatter light sideways to
the surrendered diseased tissue. If the treatment requires covering an even larger volume
of diseased tissue, the use of several smaller fibers in a bundle should also be possible [85].
This example shows that many simultaneous requirements must be met to ensure an
effective use of biodegradable and biocompatible fibers.
5. Conclusions and Outlook
We reviewed the state-of-the-art of optical fibers characterized by biodegradability
and biocompatibility, confirmed by either in vitro or in vivo studies. We discussed the
challenges posed by their manufacturing process depending on the material type. We have
seen that, besides conventional thermal drawing and extrusion processes, molding and
casting have also been investigated for producing short fibers, starting from several novel
biomaterials. Step-index fibers have been achieved by combining these techniques with
dip-coating in a lower refractive index hydrogel solution or UV-cross-linkable polymer.
This approach leads to very short fibers, which is sufficient for research into the properties
of novel biomaterial-based waveguides, but is not adequate for volume production and
for delivering meters of fibers with consistent characteristics. We therefore foresee that
standard heat-drawing or extrusion are still the most promising production technologies
that allow for economically large-scale optical fiber fabrication and that provide sufficient
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design flexibility, to obtain both step-index and microstructured fibers. Thermal drawing
requires preform fabrication, which can be a troublesome task, but the heat-drawn fibers
are typically characterized with lower roughness than their extruded counterparts, and
hence feature lower optical loss. Extrusion techniques, on the other hand, simplify fiber
fabrication as they involve a single continuous process, starting with polymer pellets and
ending with the finished fiber. The extruded fiber fabrication process is also possible on a
large scale, with limited batch-to-batch variations. The main thrust for both technologies
should come from improvements in the fabrication of low-loss standard step-index single-
mode or multimode fibers from the most promising optical biomaterials, but also from
the development of more complex optical structures, extending beyond conventional
core-cladding fibers.
The materials that we have reviewed so far typically feature a tunable degradation
rate, biocompatibility, and various mechanical and optical properties. The optical prop-
erties remain a key aspect, irrespective of the targeted application. In general the optical
performance and processing capabilities of polyesters and other thermoplastics are superior
to hydrogel materials, and would therefore be preferred. However, to mitigate against
potential tissue damage upon in vivo insertion of a fiber, the application of a hydrogel
coating onto a thermoplastic polymer fiber may be a promising strategy to “soften” the
surface of such polymer optical fibers.
To the best of our knowledge, there are no biomaterial-based optical fibers that have
already been validated for use in a clinical study. Nevertheless, many of the biomaterials
discussed in this review have been applied in other medical tools that did receive clinical
approval. For those tools, the main requirement for the biomaterial, besides its biocom-
patibility, is its capability to match the required mechanical properties and its adaptable
degradation time given a specific application. To give a few examples, silk fibroin (SF), an
FDA-approved natural protein, is commonly used in sutures, surgical meshes, and fabrics
for skin wound healing and for tissue engineering by means of scaffolds [86]. Agarose, the
major component of FDA-approved agar, gained particular attention for the fabrication of
advanced delivery systems, as sophisticated carriers for therapeutic agents [87], and these
have been tested in human trials [88]. Alginate is also FDA approved and often used in
drug- and protein-delivery systems and for wound healing treatments [89]. Cellulose is
one of the most abundant biodegradable materials in nature, and has been widely used
in medical applications such as wound dressing [90], tissue engineering [91], controllable
drug delivery system [92], treatments [93,94], and as a excipient in the pharmaceutical
industry. Poly(ethylene glycol) (PEG), poly(ε-caprolactone) (PCL), and poly(lactide-co-
glycolide) (PLGA) are synthetic polymers that have been investigated in clinical trials
and approved by the FDA for safe use in humans. PEG has been widely utilized in
biomedical applications, such as bioconjugation, in which it is either directly conjugated
with drugs or attached to the surface of drug-encapsulating nanomaterials (a technique
known as PEGylation) [95], in drug delivery [96], in biosensing (e.g., for electrochemical,
optical and mass-based biosensors) [97], and in tissue engineering [98]. PCL has recently
been considered for biomedical applications, including bone tissue engineering [99], drug
delivery [100], and as dermal and subdermal fillers, since it is an excellent collagen stim-
ulator [101]. The other attractive polymer for the fabrication of drug delivery and tissue
engineering applications is PLGA [102]. There are many commercially available PLGA-
based medical products, including membranes, sponges, powders, gels, and sutures [103],
as well as scaffolds, films, and micro- and nanoparticles utilized for the dental field [104].
The main barriers for clinical translations are associated with the use of non-FDA
approved, new chemical entities. Indeed, whilst many of the non-functionalized polymers
mentioned above are already FDA-approved, additional and separate approval is required
after functionalization and for each novel biomaterial-based medical device. Obtaining
such approval typically requires a lengthy and costly regulatory trajectory, but is a strict
necessity before the materials can be tested on humans and ultimately become part of
clinical practice.
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Consequently, and given that the field of biodegradable and biocompatible optical
fibers is still in its infancy, it is difficult to pinpoint a “killer application” for such devices
today. At the same time, owing to the progress made so far, it is our belief that they
hold promise for becoming enabling tools for diverse medical applications, such as deep-
tissue light delivery, PDT, imaging, and sensing. PDT is clinically approved for treating a
number of cancers (bladder, lung, skin, esophageal, brain, and ovarian), and has also been
demonstrated by means of optical fibers [105]. Commercially available polymer or silica
based optical fibers (e.g., manufactured by Medlight, Lausanne, Switzerland [106]) that can
be used for that purpose have a partially stripped cladding, and their core is coated with
a light-scattering material along the desired length of the diffusing tip. Considering that
PDT is already applied in the clinic, one can conjecture that material solutions supporting
this treatment could go to market first.
Moreover, there is indeed an immense potential for exploring the possibilities of
applications in which these optical fibers could be employed in the near future, such as
light-induced manipulation of cells by means of optogenetics, continuous in vivo monitor-
ing, label-free optical sensing (e.g., by means of Bragg grating peak wavelengths shifts),
and light triggered drug release implanted in the microstructures of such fibers. Optical
fibers may become frequently used parts of implantable optical components within fully
bioresorbable medical devices [107], such as the reported biosensors [108], i.e., millimeter-
scale bioresorbable Fabry-Pérot interferometers that enabled continuous measurements of
pressure and temperature [109], or in a device used for the continuous monitoring of cere-
bral temperature, oxygenation, and neural activity for the spectroscopic characterization of
targeted tissues and biofluids in living mice [110], and other devices for nerve regeneration
and optogenetics [111].
The capability to combine modern nanotechnologies with optical fibers is also an
emerging trend in advanced biosensing technology. Biological detection and optical manip-
ulation of biospecimens such as organic nanoparticles, biomolecules, and bacterial viruses,
for example, is being investigated by means of conventional silica based optical fibers [112].
Micro- and nano-optical fibers, including tapered fibers, plasmonic fibers, microlens-based
fibers, and nanowires, are excellent candidates because of their low optical loss, tight optical
confinement, and large fractional evanescent fields, making them a novel miniaturized
platform for optical sensing with higher sensitivity and spatial resolution [113]. These
fibers could be fabricated from biocompatible and bioresorbable materials to guarantee a
minimally invasive procedure and limit cytotoxicity.
The analysis of the current state-of-the-art revealed a number of important findings
on various biocompatible specialty optical fibers since the first report on bioresorbable
cellulose-based fiber was presented in 2007. Remarkably, biocompatibility, degradation,
and optical performance have been successfully shown in vitro and in animal models for
some fibers, whilst others have been employed for several proof-of-concept demonstrations.
In spite of these major achievements, several supplemental challenges should still be
addressed before large-scale practical applications in both preclinical and clinical scenarios
can be envisaged. These include, for example, the development of efficient connectors for
terminating specialty optical fibers and connecting them to, or disconnecting them from,
standard lead optical fibers that remain outside a patient’s body.
We are convinced that the unique properties of light guiding biomaterial-based fibers
can support and improve medical diagnosis and therapy and enable new future applica-
tions in photomedicine. The potential of bioresorbable and biocompatible optical fiber
technology is immense, and therefore we expect research on this topic to intensify in the
coming years.
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